Remission Survival in Juvenile Idiopathic Arthritis Showcased in New Research

Strategic Insights -

A cohort of 82 JIA patients, primarily female with a median age of 4.49 years old, was evaluated in an observational, retrospective, and longitudinal study. The primary objective was to maintain stable remission, which was achieved in nearly 80% of patients at 3 years and 68.3% at 5 years. The study found that patients without systemic treatment were more likely to achieve stable remission.

Key Takeaways:

  • The study evaluated remission survival in 82 JIA patients and found that nearly 80% maintained remission at 3 years and 68.3% at 5 years.
  • Patients without systemic treatment were more likely to achieve stable remission (47.4%) compared to those treated with methotrexate only (p=0.015).
  • The study concluded that flares were more frequent in patients treated with methotrexate in monotherapy.
  • The research highlighted the long-term remission survival in real-life conditions, with a high proportion of patients maintaining stable remission after 3 years.
  • The Wallace criteria for stable remission was used for 18 months of the Covid-19 pandemic, and two-thirds of patients reached stable remission.

Statistics:

  • 68.3% of patients were female.
  • The median age of disease onset was 4.49 years old.
  • 82 patients were included in the study.
  • Nearly 80% of patients maintained remission at 3 years.
  • 68.3% of patients were still in remission after 5 years.
  • 50.9% of patients reached stable remission throughout 18 months of the Covid-19 pandemic.
  • 57 patients (69.5%) reached stable remission throughout 18 months of the Covid-19 pandemic.

Sources:

  • NewsRx. Investigators at Hospital General Universitario Gregorio Maranon Zero in on Juvenile Rheumatoid Arthritis (Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?). Medical Letter on the CDC & FDA. October 26, 2025; p 567.
  • Real life treatment in juvenile idiopathic arthritis: Is remission long lasting? Reumatologia Clinica, 2025;21(8):501949.
  • Laura Trives-Folguera et al. (2025). Real-life treatment in juvenile idiopathic arthritis: Is remission long lasting? Reumatologia Clinica, 21(8), 501949.